News
BVNKF
30.68
NaN%
--
Bavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Order
NASDAQ · 5d ago
Weekly Report: what happened at BVNKF last week (0504-0508)?
Weekly Report · 6d ago
Weekly Report: what happened at BVNKF last week (0427-0501)?
Weekly Report · 05/04 10:32
Weekly Report: what happened at BVNKF last week (0420-0424)?
Weekly Report · 04/27 10:36
Weekly Report: what happened at BVNKF last week (0413-0417)?
Weekly Report · 04/20 10:31
Weekly Report: what happened at BVNKF last week (0406-0410)?
Weekly Report · 04/13 10:36
Weekly Report: what happened at BVNKF last week (0330-0403)?
Weekly Report · 04/06 10:36
Weekly Report: what happened at BVNKF last week (0323-0327)?
Weekly Report · 03/30 10:36
Weekly Report: what happened at BVNKF last week (0316-0320)?
Weekly Report · 03/23 10:32
Weekly Report: what happened at BVNKF last week (0309-0313)?
Weekly Report · 03/16 10:31
Weekly Report: what happened at BVNKF last week (0302-0306)?
Weekly Report · 03/09 10:32
Weekly Report: what happened at BVNKF last week (0223-0227)?
Weekly Report · 03/02 10:31
Weekly Report: what happened at BVNKF last week (0216-0220)?
Weekly Report · 02/23 10:31
Weekly Report: what happened at BVNKF last week (0209-0213)?
Weekly Report · 02/16 10:31
Weekly Report: what happened at BVNKF last week (0202-0206)?
Weekly Report · 02/09 10:32
Weekly Report: what happened at BVNKF last week (0126-0130)?
Weekly Report · 02/02 10:32
Weekly Report: what happened at BVNKF last week (0119-0123)?
Weekly Report · 01/26 10:32
Bavarian Nordic Grants Exclusive Distribution Rights Of Chikungunya Vaccine To Eurofarma
NASDAQ · 01/23 12:20
Weekly Report: what happened at BVNKF last week (0112-0116)?
Weekly Report · 01/19 10:39
Weekly Report: what happened at BVNKF last week (0105-0109)?
Weekly Report · 01/12 10:38
More
Webull provides a variety of real-time BVNKF stock news. You can receive the latest news about Bavarian Nordic through multiple platforms. This information may help you make smarter investment decisions.
About BVNKF
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.